Dyno Therapeutics

Description

Builds high-performance genetic technologies to improve AAV gene delivery for gene therapy, supporting therapeutic developers working on next-generation genetic medicines for patients.

Related

• AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene…
• Forge BiologicsProvides high-yield AAV manufacturing, process development, cGMP production, and analytical services for gene therapy developers advancing…
• Arbor BiotechnologiesDevelops gene editing treatments and genetic medicines using programmable DNA editors for people with genetic diseases, with a focus on CNS…
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods,…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• Capsida BiotherapeuticsDevelops targeted genetic medicines and engineered capsids for neurological and ocular diseases, including IV-delivered CNS gene therapies…
• bluebird bioDevelops one-time gene addition treatments for rare hematologic diseases, using patients' own cells and patient support services to help…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Tessera TherapeuticsDevelops Gene Writing technology and non-viral delivery methods to make targeted genome alterations for therapies addressing major unmet…
• Krystal Biotech ($KRYS)Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors…
• Colossal BiosciencesDevelops CRISPR-based genomics software tools and genetic engineering programs for de-extinction, including work on woolly mammoths using…
• InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics…